Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles.
Scope of the Report:
This report focuses on the Follicle Stimulating Hormone in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). It is mainly used to treat infertility disease and assisted reproductive technology. At present, this product cannot be replaced in the treatment of infertility.
Currently, There are only several companies producing this product, such as Merck Serono, MSD, IBSA, Ferring, Livzon and Techwell etc. Merck Serono and MSD are top two companies in the world. In 2016, Merck Serono takes about 58.70% of global follicle stimulating hormone revenue. MSD takes about 26.29% of global follicle stimulating hormone revenue.
The worldwide market for Follicle Stimulating Hormone is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to Research study.
Curious about this latest version of report?
Get a FREE sample Copy of this report : https://www.topkeyplayers.com/market-reports/follicle-stimulating-hormone-market-28178/#tab-request_sample
Market Segment by Companies, this report covers
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
Assisted Reproductive Technology
There are 15 Chapters to deeply display the global Follicle Stimulating Hormone market.
Chapter 1, to describe Follicle Stimulating Hormone Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Follicle Stimulating Hormone, with sales, revenue, and price of Follicle Stimulating Hormone, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Follicle Stimulating Hormone, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Follicle Stimulating Hormone market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Follicle Stimulating Hormone sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
TopKeyPlayers.com is a global business market research providing syndicated research Report, customized research reports, company profiles and industry databases across multiple domains.
We provide intellectual, precise and meaningful data at a lightning speed.
We host more than 500,000 Industry research products.
304, S. Jones Blvd, #3299,
Las Vegas, NV 89107
USA : +1 702-425-8599
Email : Sales@TopKeyPlayers.com
Web : https://www.TopKeyPlayers.com
Aira McDonald is a seasoned journalist with nearly 15 years experience. While studying journalism at the University of Detroit,, Aira found a passion for finding engaging stories. As a contributor to PR News Globe, Aira mostly covers human interest pieces.